Adding Inhibrx Biosciences’ OX40…
Adding Inhibrx Biosciences’ OX40 agonist to Keytruda doubled the response [...]
A quantum tech firm that has…
A quantum tech firm that has collaborated with—and received investment [...]
Novo Nordisk has found the latest…
Novo Nordisk has found the latest buyer for one of [...]
Leerink Partners analysts slashed…
Leerink Partners analysts slashed their sales forecast for enGene Therapeutics’ [...]
Odyssey Therapeutics has become…
Odyssey Therapeutics has become the latest biotech to voyage to [...]
Not long after the departure of…
Not long after the departure of former CEO Usman Azam, [...]
BeOne Medicines has shaken up its…
BeOne Medicines has shaken up its early pipeline, dropping five [...]
Ascendis Pharma has ended internal…
Ascendis Pharma has ended internal development of its IL-2 candidate, [...]
For people living with exocrine…
For people living with exocrine pancreatic insufficiency due to cystic [...]
Entrada Therapeutics’ Duchenne…
Entrada Therapeutics’ Duchenne muscular dystrophy data have fallen well short [...]